1. Health technology

  2. •

    Medical specialties
Ypsomed Holding AG

Ypsomed Holding AG

OOTC:YPHDF
436.55
USD
-64.45
(-12.86%)
4.77BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
21.83
24.21
26.61
30.79
36.92
35.89
31.19
31.91
36.76
37.07
40.18
54.87
53.72
- -
Basic EPS, GAAP
1.08
1.53
2.83
3.66
4.12
4.76
0.93
0.46
1.83
3.82
5.74
6.41
16.31
- -
Free Cash Flow per Basic Share
0.84
0.86
3.2
2.92
-1.09
-5.47
-5.51
-3.22
-3.3
-2.95
-2.35
-9.45
-1.2
- -
Dividend per Share
0.2
0.3
0.6
1
1.3
1.4
0.55
0.2
1.16
0.61
1.3
2
2.21
- -
Book Value per Share
18.03
19
21.17
23.84
27.02
29.96
29.87
31.18
30.94
41.2
45.26
49.81
56.91
56.91
Tangible Book Value per Share
13.19
13.55
15.4
18.03
20.92
23.52
21.76
18.5
15.9
24.22
24.63
27.06
47.35
47.35
Basic Weighted Avg Shares
13
13
13
13
13
13
13
13
13
13
14
14
14
14
Sales/Revenue/Turnover
276
307
337
390
466
454
394
404
465
497
548
749
731
- -
Operating Margin (%)
5.66
9.31
13.19
14.2
13.1
16.16
2.46
2.3
6.15
12.18
15.72
15.07
33.66
- -
Depreciation Expense
25
26
27
31
34
45
53
56
68
79
75
80
82
- -
Net Income, GAAP
14
19
36
46
52
60
12
6
23
51
78
88
222
- -
Effective Tax Rate (%)
10.73
18.28
17.1
16.51
15.97
13.94
- -
4.94
9.53
9.47
4.28
16.11
7.9
- -
Profit Margin (%)
4.93
6.33
10.63
11.87
11.17
13.25
2.98
1.44
4.97
10.31
14.29
11.68
30.36
- -
Working Capital
12
23
43
72
76
-9
-86
-87
-44
-51
-102
-69
21
21
LT Debt
20
15
10
10
10
10
10
33
110
- -
- -
100
112
112
Total Equity
228
241
268
302
342
379
378
395
393
562
618
680
748
748
Return on Invested Capital (%)
4.54
7.47
11.74
14.05
13.69
13.8
- -
1.46
4.07
7.95
10.31
9.73
21.53
- -
Return on Capital (%)
4.75
6.46
11.62
14.3
14.16
13.46
- -
1.26
3.93
7.71
10.42
9.69
21.88
- -
Return on Common Equity (%)
6.11
8.27
14.09
16.24
16.18
16.7
3.1
1.5
5.86
10.74
13.28
13.49
31.09
- -

Capital Structure

CHF

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
267
- -
149
LT Borrowings
100
- -
112
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
13
13
Market Capitalization
4,351
5,034
3,810

Working Capital

CHF

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
427
370
321
Cash, Cash Equivalents & STI
36
36
29
Accounts Receivable, Net
174
142
187
Inventories
86
69
61
Total Current Liabilities
496
252
301
Payables & Accruals
- -
- -
- -
ST Debt
267
- -
149
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.36%
14.5%
10.07%
Free Cash Flow
40.66%
38.57%
-87.33%
Net Income, GAAP
56.39%
127.53%
153.62%
Sales/Revenue/Turnover
8.85%
13.32%
-2.39%
Total Cash Common Dividend
59.79%
123.62%
9.97%

Quarterly Revenue

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
548
2025
- -
- -
- -
- -
749
2026
- -
- -
- -
- -
731

Quarterly Earnings Per Share

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5.74
2025
- -
- -
- -
- -
6.41
2026
- -
- -
- -
- -
16.31

Quarterly Dividends Per Share

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.3
2025
- -
- -
- -
- -
2
2026
- -
- -
- -
- -
2.21

Company Description

Company Profile APIChatGPT
Address
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business

Company News

Company News APIChatGPT

  • seekingalpha.com

    Ypsomed Holding AG (YPHDF) Q4 2026 Earnings Call Transcript